(Reuters) – A U.S. health panel may soon make HIV testing as standard a practice as checking cholesterol levels, a move that would fundamentally change how the virus is detected and treated.The U.S. Preventive Services Task force, a government-backed group of clinicians and scientists, is expected t

(Reuters Health) – The short-term benefits of weight loss surgery are well known in severely obese people, but a new study finds that improvements in diabetes and blood pressure may hold up for years after the procedures.At six-year patient follow-ups, three quarters of people who’d undergone gastri

The development of artificial intelligence (AI) in healthcare is advancing rapidly and playing an important role in healthcare worldwide. However, real-world implementation remains challenging in terms of economic value, patient data security, and acceptance by health professionals. Hence, this study was conducted with three main components: (1) a

Apiwat Piriyapol is a research associate at Medical Innovation Development and Assessment Support (MIDAS). His training was in labour economics with experience in urban health economics. His current interest is in conducting medical technology assessment to promote advanced technology to the healthcare system.

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

66183067HM017L0health economic evaluation,health technology assessment,medical innovation,research and development,target product profiles

This study aims to assess both the cost and the appropriate medical indications of using Positron Emission Tomography-Computed Tomography (PET-CT) under the Thai setting. It also estimates the potential need and supply to meet the need of PET-CT within the next five years. A systematic review and meta-analysis of literature published in the PubMed

An aim of this study is to describe quantitatively and qualitatively progression and findings from the HTA topic selection process recently developed by HITAP. The process involves potential users of HTA information; namely (1) third party payers (public health insurers), (2) national health care program managers (Ministry of Public Health’s Depa

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement

HITAP, in collaboration with the Center for the Evaluation of Value and Risk in Health, Tufts Medical Cent, conducted an analysis of existing capacity for conducting economic evaluations in the African region using the Tufts Medical Center CEA Registries. The findings of the study were presented at the PMAC 2020 side meeting “Attain & Sustain